APLN and meningioma: These represented pathways that may be amenable to drug targeting effective for both meningioma and VS and include apelin and G protein-coupled receptor signalling, calcium and neurotransmitter signalling, nitric oxide signalling, adherens junction remodelling, and vesicle transport (Supplementary Fig. 2).